CureVac

Pfizer, BioNTech Seek to Revoke CureVac’s Patent Infringement Claims

Pfizer and its German partner BioNTech have filed proceedings at the High Court of England and Wales, seeking a judgment that their COVID-19 vaccine, based on mRNA technology, does not ...

September 5, 2022BY Reuters
BioNTech, Pfizer Sue CureVac in US Over COVID-19 Vaccine Patent Claims

FRANKFURT—COVID-19 vaccine maker BioNTech said on Tuesday that it and partner Pfizer have filed a complaint with the ...

July 28, 2022BY Reuters
CureVac Files Patent Lawsuit in Germany Against BioNTech

BERLIN—CureVac has filed a patent lawsuit in Germany against BioNTech over its use of mRNA technology, marking one ...

July 6, 2022BY Reuters
CureVac COVID-19 Vaccine Records 48 Percent Efficacy in Final Trial Readout

CureVac reported on June 30 that its COVID-19 vaccine was 48 percent effective in the final analysis of ...

July 1, 2021BY Reuters